2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
By F. Visseren, F. Mach, Y. Smulders, D. Carballo, K. Koskinas, Maria Bäck, A. Benetos, A. Biffi, J. Boavida, D. Capodanno and 95 more. European Heart Journal, 2021
5,029 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Economics and Econometrics, Surgery
View Paper: https://www.semanticscholar.org/paper/c1c77c40fa989a33cdc71818a98387b54f684916
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Economics and Econometrics
In Surgery
Citations in the corpus
- Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association (2023, background): “120 In addition, the CKM factors of diabetes and hypertension increase stroke risk in atrial fibrillation, favoring the use of anticoagulation for stroke prophylaxis.”
- A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association (2023, background): “63 In the primary prevention population, there are key questions about the value and net benefit of adding PCSK9 inhibitors or other novel LDL-lowering therapies to statins and ezetimibe.”
- 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. (2024, positive): “209,210 Smoking cessation reduces overall cardiovascular risk but not BP.”